Caption Management’s BioNTech BNTX Stock Holding History

Caption Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,000	Closed	-$2.85M	–	1547
2024 Q4	$2.85M	Buy	+25,000	New	+$2.85M	0.03%	571
2022 Q1	–	Sell	-12,500	Closed	-$3.22M	–	1476
2021 Q4	$3.22M	Hold	12,500	–	–	0.04%	614
2021 Q3	$3.41M	Buy	+12,500	New	+$3.97M	0.04%	582
2020 Q4	–	Sell	-331,400	Closed	-$22.9M	–	980
2020 Q3	$22.9M	Buy	+331,400	New	+$23.8M	0.54%	25

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caption Management's BNTX Position: Q1 2026 in Review

Caption Management reduced its BioNTech (BNTX) stake by 36% in Q1 2026, selling an estimated $257K and leaving 4,500 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

Caption Management first reported a position in BNTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $1.12M in Q2 2020. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Caption Management held 4,500 shares of BioNTech worth $400K as of Q1 2026.
Caption Management sold 2,500 BioNTech shares in Q1 2026, an estimated $257K.
BioNTech made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1249 holding.
Caption Management first reported a position in BioNTech in Q2 2020 and has held it in 6 quarters since.
Caption Management's BioNTech position peaked at $1.12M in Q2 2020.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.